Quest Diagnostics, Inc’s recent filing unveils that its CEO and President Davis J. E. unloaded Company’s shares for reported $6.6 million on Apr 02 ’25. In the deal valued at $168.46 per share,39,191 shares were sold. As a result of this transaction, Davis J. E. now holds 127,623 shares worth roughly $20.95 million.
Then, KUPPUSAMY KARTHIK sold 2,555 shares, generating $434,350 in total proceeds. Upon selling the shares at $170.00, the SVP, Clinical Solutions now owns 10,575 shares.
Before that, Davis J. E. bought 39,191 shares. Quest Diagnostics, Inc shares valued at $6,662,470 were divested by the Officer at a price of $170.00 per share.
Redburn Atlantic initiated its Quest Diagnostics, Inc [DGX] rating to a Buy in a research note published on April 02, 2025; the price target was $195. A number of analysts have revised their coverage, including Citigroup’s analysts, who decreased its forecast for the stock in early March from “a Buy” to “a Neutral”. Leerink Partners also remained covering DGX and has increased its forecast on January 06, 2025 with a “an Outperform” recommendation from previously “Market perform” rating. Morgan Stanley revised its rating on December 17, 2024. It rated DGX as “an Overweight” which previously was an “an Equal-weight”.
Price Performance Review of DGX
On Friday, Quest Diagnostics, Inc [NYSE:DGX] saw its stock fall -3.78% to $164.18. Over the last five days, the stock has lost -1.88%. Quest Diagnostics, Inc shares have risen nearly 8.83% since the year began. Nevertheless, the stocks have risen 24.01% over the past one year. While a 52-week high of $178.87 was reached on 03/10/25, a 52-week low of $125.42 was recorded on 01/16/25. SMA at 50 days reached $167.96, while 200 days put it at $155.73.
Levels Of Support And Resistance For DGX Stock
The 24-hour chart illustrates a support level at 160.91, which if violated will result in even more drops to 157.63. On the upside, there is a resistance level at 170.38. A further resistance level may holdings at 176.57. The Relative Strength Index (RSI) on the 14-day chart is 42.34, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.14, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 95.66%. Stochastics %K at 34.84% indicates the stock is a holding.
How much short interest is there in Quest Diagnostics, Inc?
A steep rise in short interest was recorded in Quest Diagnostics, Inc stocks on 2025-03-14, dropping by -0.19 million shares to a total of 2.76 million shares. Yahoo Finance data shows the prior-month short interest on 2025-02-14 was 2.96 million shares. There was a decline of -7.04%, which implies that there is a negative sentiment for the stock.
